The results of a University of Maryland (UMD)-led study could point to new and improved treatment approaches for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes ...
Sentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases Zokinvy is approved in the U.S. (2020), ...
A rare, but fatal genetic disease that accelerates aging in children, progeria, could soon have a cure, The New York Times reported July 24. The disease affects only 1 in every 4 million to 8 million ...
Proposed working model. Progerin accumulation induces stress, leading to attenuation of Ang2 expression and secretion and its downstream effector. Ang2-induced activation of Tie2 receptor activates ...
A new research paper was published in Volume 17, Issue 9 of Aging-US on August 27, 2025, titled, "Deregulated miR-145 and miR-27b in Hutchinson-Gilford progeria syndrome: implications for adipogenesis ...
In the spring of 2005, families affected by progeria welcomed the news from two studies that uncovered new information about this rare, devastating condition that causes premature aging in children.
Discovered: Pediatricians warn of trampoline's dangers; a treatment for progeria; virus touted as cure for pimples; research universities in financial straits. First-ever treatment for progeria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results